SCHEMBL11199596

SCHEMBL11199596

ClCCC1CCCN(Cc2ccccc2)C1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.60
ALDH1A1 P00352 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C19 P33261 1/20 0.60
BCHE P06276 4/20 0.56
ACHE P22303 2/20 0.53
MAOB P27338 1/20 0.53
CCR3 P51677 1/20 0.53
CARM1 Q86X55 1/20 0.51
PRMT6 Q96LA8 1/20 0.51
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21812109 0.88 CTSS (0.61) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL9598912 0.88 CTSS (0.61) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL11194018 0.87 CYP2D6 (0.64) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL10684393 0.87 BCHE (0.70) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL8238364 0.87 BCHE (0.70) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL10212322 0.86 CYP2D6 (0.59) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL7514732 0.86 CYP2D6 (0.59) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL12513821 0.86 CYP2D6 (0.59) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL7337185 0.86 CYP2D6 (0.66) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL28952283 0.85 CYP2D6 (0.57) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4405623-A HYPOTENSIVE AGENTS, VASODILATORS MASAYUKI ISHIKAWA (JP) 1983-09-20 US disclosed
EP-0040793-A1 Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof Ishikawa, Masayuki (JP) 1981-12-02 EP disclosed